Fexaramine Shows Promise for Weight Loss
Orally delivered fexaramine had favorable effects on metabolic profiles in mice and may be effective for weight loss in humans.
All articles by Kathy Boltz, PhD
Acarbose May Pose Higher Cardiovascular Risk Than Metformin
Robert W Lash, MD, of the Endocrine Society, finds this study interesting and useful, but not a stinging indictment of acarbose.
Cigarette Cravings Fluctuate Across Menstrual Cycle
Gender-specific programs accounting for a woman’s menstrual cycle may help women quit smoking.
Intense Training and Endocrine Disorders in Young Female Athletes
Young female athletes my experience endocrine disorders, including menstrual problems and difficulty with bone mass, due to intense training.
NT-proBNP Improves Cardiovascular Disease Risk Prediction in Women
N-terminal B-type natriuretic peptide concentrations may be an indicator of cardiovascular disease risk in women.
Unraveling the Mystery of Troglitazone Hepatotoxicity
A systems pharmacology model may predict hepatotoxicity associated with troglitazone.
Post-Thyroidectomy Hypocalcemia Predictors Identified
Richard Quinton, MD, offers his take on these study findings and what they may mean for clinical practice.
DHEA Levels May Predict Coronary Heart Disease Risk in Elderly Men
Low levels of dehydroepiandrosterone (DHEA) and its sulfate may predict increased risk for coronary heart disease in men.
Next post in Adrenal
